Assembly Biosciences Inc (ASMB)
13.00
+0.08
(+0.62%)
USD |
NASDAQ |
Apr 18, 12:54
Assembly Biosciences Total Liabilities (Quarterly): 95.73M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 95.73M |
September 30, 2023 | 9.915M |
June 30, 2023 | 11.63M |
March 31, 2023 | 12.78M |
December 31, 2022 | 19.13M |
September 30, 2022 | 19.11M |
June 30, 2022 | 19.47M |
March 31, 2022 | 15.94M |
December 31, 2021 | 22.13M |
September 30, 2021 | 24.33M |
June 30, 2021 | 30.34M |
March 31, 2021 | 31.66M |
December 31, 2020 | 42.68M |
September 30, 2020 | 35.76M |
June 30, 2020 | 27.69M |
March 31, 2020 | 61.54M |
December 31, 2019 | 66.69M |
September 30, 2019 | 66.86M |
June 30, 2019 | 66.80M |
March 31, 2019 | 68.85M |
December 31, 2018 | 57.39M |
September 30, 2018 | 53.54M |
June 30, 2018 | 53.32M |
March 31, 2018 | 53.64M |
December 31, 2017 | 56.18M |
Date | Value |
---|---|
September 30, 2017 | 65.18M |
June 30, 2017 | 66.24M |
March 31, 2017 | 66.40M |
December 31, 2016 | 18.24M |
September 30, 2016 | 19.08M |
June 30, 2016 | 16.64M |
March 31, 2016 | 15.17M |
December 31, 2015 | 15.00M |
September 30, 2015 | 14.25M |
June 30, 2015 | 13.84M |
March 31, 2015 | 13.73M |
December 31, 2014 | 12.65M |
September 30, 2014 | 13.19M |
June 30, 2014 | 1.470M |
March 31, 2014 | 1.462M |
December 31, 2013 | 2.638M |
September 30, 2013 | 2.318M |
June 30, 2013 | 2.585M |
March 31, 2013 | 1.977M |
December 31, 2012 | 2.746M |
September 30, 2012 | 2.681M |
June 30, 2012 | 3.392M |
March 31, 2012 | 3.853M |
December 31, 2011 | 2.513M |
September 30, 2011 | 1.183M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.915M
Minimum
Sep 2023
95.73M
Maximum
Dec 2023
35.80M
Average
27.69M
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
Petros Pharmaceuticals Inc | 21.32M |
Spectral AI Inc | 10.88M |
NovaBay Pharmaceuticals Inc | 5.72M |
Palatin Technologies Inc | 24.94M |
iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 136.82M |
Shareholders Equity (Quarterly) | 41.10M |
Current Ratio | 3.411 |